Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Total Current Liabilities

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Current Liabilities ₹944 Cr₹973 Cr₹683 Cr₹710 Cr₹526 Cr

What is the latest Total Current Liabilities ratio of NATCO PHARMA ?

The latest Total Current Liabilities ratio of NATCO PHARMA is ₹944 Cr based on Mar2025 Consolidated results.
Year Total Current Liabilities
Mar2025₹944 Cr
Mar2024₹973 Cr
Mar2023₹683 Cr
Mar2022₹710 Cr
Mar2021₹526 Cr

How is Total Current Liabilities of NATCO PHARMA Trending?

Years Total Current Liabilities % Change
Mar2025 ₹944 Cr
-3.01
Mar2024 ₹973 Cr
42.41
Mar2023 ₹683 Cr
-3.84
Mar2022 ₹710 Cr
35.16
Mar2021 ₹526 Cr -

Compare Total Current Liabilities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹16,045.6 Cr -3% 1.6% -33.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,086.0 Cr -1.5% -4.8% -4.2% Stock Analytics
DIVIS LABORATORIES ₹169,616.0 Cr -1.9% -1.6% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,361.0 Cr 0.3% 1.6% 12.1% Stock Analytics
CIPLA ₹120,713.0 Cr -1.2% -2% 2% Stock Analytics
DR REDDYS LABORATORIES ₹105,881.0 Cr -1.2% 1.5% -6.1% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-3%

1.6%

-33.8%

SENSEX

-0.3%

-1.1%

7.8%


You may also like the below Video Courses